Nolan Mangini Siobhan's most recent trade in Alight Inc. - Ordinary Shares - Class A was a trade of 10,954 Class A Common Stock done . Disclosure was reported to the exchange on Jan. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alight Inc. - Ordinary Sha... | Siobhan Nolan Mangini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 10,954 | 28,789 | - | 0 | Class A Common Stock | |
| Alight Inc. - Ordinary Sha... | Nolan Mangini Siobhan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 17,835 | 17,835 | - | 0 | Class A Common Stock | |
| Ngm Biopharmaceuticals Inc | Siobhan Nolan Mangini | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 228,000 | 228,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Siobhan Nolan Mangini | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Siobhan Nolan Mangini | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 76,000 | 76,000 (0%) | 0% | 0 | Common Stock | |
| Ngm Biopharmaceuticals Inc | Siobhan Nolan Mangini | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Siobhan Nolan Mangini | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Siobhan Nolan Mangini | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |